Anavex Life Sciences Corp. (AVXL)
3.105
-0.14
(-4.17%)
USD |
NASDAQ |
Aug 24, 16:00
3.10
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Market Cap : 287.75M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 300.26M |
| August 20, 2026 | 290.06M |
| August 19, 2026 | 314.16M |
| August 18, 2026 | 296.55M |
| August 17, 2026 | 297.48M |
| August 14, 2026 | 298.40M |
| August 13, 2026 | 303.04M |
| August 12, 2026 | 316.01M |
| August 11, 2026 | 325.28M |
| August 10, 2026 | 314.16M |
| August 07, 2026 | 309.52M |
| August 06, 2026 | 303.96M |
| August 05, 2026 | 296.55M |
| August 04, 2026 | 291.92M |
| August 03, 2026 | 273.38M |
| July 31, 2026 | 254.85M |
| July 30, 2026 | 250.21M |
| July 29, 2026 | 230.75M |
| July 28, 2026 | 238.17M |
| July 27, 2026 | 231.68M |
| July 24, 2026 | 222.41M |
| July 23, 2026 | 229.83M |
| July 22, 2026 | 236.31M |
| July 21, 2026 | 236.78M |
| July 20, 2026 | 224.27M |
| Date | Value |
|---|---|
| July 17, 2026 | 221.49M |
| July 16, 2026 | 216.85M |
| July 15, 2026 | 231.68M |
| July 14, 2026 | 225.19M |
| July 13, 2026 | 217.78M |
| July 10, 2026 | 231.68M |
| July 09, 2026 | 250.21M |
| July 08, 2026 | 250.21M |
| July 07, 2026 | 251.14M |
| July 06, 2026 | 246.51M |
| July 02, 2026 | 255.77M |
| July 01, 2026 | 239.09M |
| June 30, 2026 | 240.02M |
| June 29, 2026 | 240.95M |
| June 26, 2026 | 242.80M |
| June 25, 2026 | 228.44M |
| June 24, 2026 | 237.24M |
| June 23, 2026 | 239.09M |
| June 22, 2026 | 235.39M |
| June 18, 2026 | 252.99M |
| June 17, 2026 | 247.43M |
| June 16, 2026 | 233.53M |
| June 15, 2026 | 231.68M |
| June 12, 2026 | 231.68M |
| June 11, 2026 | 231.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tenaya Therapeutics, Inc. | 149.94M |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
| Oncolytics Biotech, Inc. | 105.94M |
| Sangamo Therapeutics, Inc. | 58.95M |
| Sarepta Therapeutics, Inc. | 1.915B |
Market Cap Related Metrics
| Price to Book Value | 2.273 |
| Price | 3.105 |
| Earnings Yield | -12.59% |